AAAAAA

   
Results: 1-21 |
Results: 21
T-cell recovery in adults and children following umbilical cord blood transplantation
Authors: Klein, AK Patel, DD Gooding, ME Sempowski, GD Chen, BJ Liu, CX Kurtzberg, J Haynes, BF Chao, NJ
Citation: Ak. Klein et al., T-cell recovery in adults and children following umbilical cord blood transplantation, BIOL BLOOD, 7(8), 2001, pp. 454-466
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
Authors: Boeckh, M Bowden, RA Storer, B Chao, NJ Spielberger, R Tierney, DK Gallez-Hawkins, G Cunningham, T Blume, KG Levitt, D Zaia, JA
Citation: M. Boeckh et al., Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation, BIOL BLOOD, 7(6), 2001, pp. 343-351
Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome inbreast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation
Authors: McGaughey, DS Nikcevich, DA Long, GD Vredenburgh, JJ Rizzieri, D Smith, CA Broadwater, G Loftis, FS McDonald, C Morris, AK Folz, RJ Chao, NJ
Citation: Ds. Mcgaughey et al., Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome inbreast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation, BIOL BLOOD, 7(5), 2001, pp. 274-278
Acute graft-vs-host disease: Pathobiology and management (vol 29, pg 259, 2001)
Authors: Goker, H Haznedaroglu, IC Chao, NJ
Citation: H. Goker et al., Acute graft-vs-host disease: Pathobiology and management (vol 29, pg 259, 2001), EXP HEMATOL, 29(5), 2001, pp. 653-653
Acute graft-vs-host disease: Pathobiology and management
Authors: Goker, H Haznedaroglu, IC Chao, NJ
Citation: H. Goker et al., Acute graft-vs-host disease: Pathobiology and management, EXP HEMATOL, 29(3), 2001, pp. 259-277
Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen
Authors: Rizzieri, DA Long, GD Vredenburgh, JJ Gasparetto, C Morris, A Stenzel, TT Davis, P Chao, NJ
Citation: Da. Rizzieri et al., Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen, BLOOD, 98(12), 2001, pp. 3486-3488
High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial
Authors: Horning, SJ Negrin, RS Hoppe, RT Rosenberg, SA Chao, NJ Long, GD Brown, BW Blume, KG
Citation: Sj. Horning et al., High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial, BLOOD, 97(2), 2001, pp. 404-409
Progress in graft-versus host disease
Authors: Chao, NJ
Citation: Nj. Chao, Progress in graft-versus host disease, J HEMATH ST, 9(3), 2000, pp. 295-296
Graft-versus-host disease prevention by rapamycin: Cellular mechanisms
Authors: Chen, BJ Morris, RE Chao, NJ
Citation: Bj. Chen et al., Graft-versus-host disease prevention by rapamycin: Cellular mechanisms, BIOL BLOOD, 6(5A), 2000, pp. 529-536
Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor"mobilization of peripheral blood progenitor cells
Authors: Stockerl-Goldstein, KE Reddy, SA Horning, SJ Blume, KG Chao, NJ Hu, WW Johnston, LJ Long, GD Strober, S Wong, RM Feiner, RH Kohler, S Negrin, RS
Citation: Ke. Stockerl-goldstein et al., Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor"mobilization of peripheral blood progenitor cells, BIOL BLOOD, 6(5), 2000, pp. 506-512
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma
Authors: Alvarnas, JC Negrin, RS Horning, SJ Hu, WW Long, GD Schriber, JR Stockerl-Goldstein, K Tierney, K Wong, R Blume, KG Chao, NJ
Citation: Jc. Alvarnas et al., High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma, BIOL BLOOD, 6(3A), 2000, pp. 352-358
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens:Results of a prospective double-blind randomized trial
Authors: Chao, NJ Snyder, DS Jain, M Wong, RM Niland, JC Negrin, RS Long, GD Hu, WW Stockerl-Goldstein, KE Johnston, LJ Amylon, MD Tierney, DK O'Donnell, MR Nademanee, AP Parker, P Stein, A Molina, A Fung, H Kashyap, A Kohler, S Spielberger, R Krishnan, A Rodriguez, R Forman, SJ Blume, KG
Citation: Nj. Chao et al., Equivalence of 2 effective graft-versus-host disease prophylaxis regimens:Results of a prospective double-blind randomized trial, BIOL BLOOD, 6(3), 2000, pp. 254-261
Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy
Authors: Hu, WW Negrin, RS Stockerl-Goldstein, K Johnston, LJ Shizuru, JA Wong, RM Chao, NJ Long, GD Feiner, RH Blume, KG
Citation: Ww. Hu et al., Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy, BIOL BLOOD, 6(1), 2000, pp. 58-69
Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
Authors: Bhalla, KS Wilczynski, SW Abushamaa, AM Petros, WP McDonald, CS Loftis, JS Chao, NJ Vredenburgh, JJ Folz, RJ
Citation: Ks. Bhalla et al., Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support, AM J R CRIT, 161(1), 2000, pp. 17-25
Conversion of indwelling chest port catheters to tunneled central venous catheters
Authors: Brodwater, BK Silber, JS Smith, TP Chao, NJ Suhocki, PV Ryan, JM Newman, GE
Citation: Bk. Brodwater et al., Conversion of indwelling chest port catheters to tunneled central venous catheters, J VAS INT R, 11(9), 2000, pp. 1137-1142
Cyclosporin A-related cerebral vasculopathy
Authors: Shbarou, RM Chao, NJ Morgenlander, JC
Citation: Rm. Shbarou et al., Cyclosporin A-related cerebral vasculopathy, BONE MAR TR, 26(7), 2000, pp. 801-804
Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion
Authors: Chen, BJ Liu, CX Gui, XY Fidler, JM Chao, NJ
Citation: Bj. Chen et al., Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion, TRANSPLANT, 70(10), 2000, pp. 1442-1447
PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice
Authors: Chen, YF Zeng, DF Schlegel, PG Fidler, J Chao, NJ
Citation: Yf. Chen et al., PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice, BLOOD, 95(2), 2000, pp. 705-710
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer
Authors: Hu, WW Long, GD Stockerl-Goldstein, KE Johnston, LJ Chao, NJ Negrin, RS Blume, KG
Citation: Ww. Hu et al., A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer, CLIN CANC R, 5(11), 1999, pp. 3411-3418
A predictive model for relapse in high-risk primary breast cancer patientstreated with high-dose chemotherapy and autologous stem-cell transplant
Authors: Nieto, Y Cagnoni, PJ Shpall, EJ Xu, XS Murphy, J Vredenburgh, J Chao, NJ Bearman, SI Jones, RB
Citation: Y. Nieto et al., A predictive model for relapse in high-risk primary breast cancer patientstreated with high-dose chemotherapy and autologous stem-cell transplant, CLIN CANC R, 5(11), 1999, pp. 3425-3431
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support
Authors: Rizzieri, DA Vredenburgh, JJ Jones, R Ross, M Shpall, EJ Hussein, A Broadwater, G Berry, D Petros, WP Gilbert, C Affronti, ML Coniglio, D Rubin, P Elkordy, M Long, GD Chao, NJ Peters, WP
Citation: Da. Rizzieri et al., Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support, J CL ONCOL, 17(10), 1999, pp. 3064-3074
Risultati: 1-21 |